HEART FAILURE WITH MID RANGE EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MID RANGE EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MID RANGE EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MID RANGE EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart MRI breakthrough: new scan could replace needle biopsy for rare heart disease
Diagnosis CompletedThis study tested whether a special type of heart MRI, called T1 mapping, can accurately diagnose cardiac amyloidosis—a condition where abnormal proteins build up in the heart muscle. Researchers studied 112 older adults with heart failure and thickened heart walls. They compared…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Could a diabetes drug ease heart failure in rare amyloid disease?
Symptom relief CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking distance, and heart stress markers ov…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC